Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0N8YG
|
||||
| Former ID |
DNC006059
|
||||
| Drug Name |
1-((S)-2-aminopropyl)-7-methyl-1H-indazol-6-ol
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [527952] | ||
| Formula |
C11H15N3O
|
||||
| Canonical SMILES |
CC1=C2C(=CNN2CC(C)N)C=CC1=O
|
||||
| InChI |
1S/C11H15N3O/c1-7(12)6-14-11-8(2)10(15)4-3-9(11)5-13-14/h3-5,7,13H,6,12H2,1-2H3
|
||||
| InChIKey |
MIBVBASXMOZOBF-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 2C receptor | Target Info | Inhibitor | [527952] | |
| 5-hydroxytryptamine 2B receptor | Target Info | Inhibitor | [527952] | ||
| 5-hydroxytryptamine 2A receptor | Target Info | Inhibitor | [527952] | ||
| WikiPathways | Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | ||||
| Monoamine GPCRs | |||||
| GPCRs, Class A Rhodopsin-like | |||||
| Gastrin-CREB signalling pathway via PKC and MAPK | |||||
| GPCR ligand binding | |||||
| GPCR downstream signalingWP732:Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
| GPCR downstream signalingWP733:Serotonin Receptor 2 and STAT3 Signaling | |||||
| SIDS Susceptibility Pathways | |||||
| GPCR downstream signaling | |||||
| GPCRs, Other | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.